Centre Hospitalier Universitaire (CHU) de Toulouse - Hôpital des Enfants | ClinicalTrials HQ

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia	Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, cutaneous mucinosis, endocrine system disorder, hereditary disease, hypochondroplasia, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4, musculoskeletal system disorder, osteochondrodysplasia	Enrolling by invitation	Phase 2	2026-08-26		NCT07393373
Prospective Clinical Assessment Study in Children With Hypochondroplasia	Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, cutaneous mucinosis, endocrine system disorder, hereditary disease, hypochondroplasia, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4, musculoskeletal system disorder, osteochondrodysplasia	Recruiting	Not stated	2026-07-16		NCT06410976
Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome	Hyperphagia in Prader-Willi Syndrome	Active, not recruiting	Phase 3	2025-09-10		NCT06173531